Chemotherapy News, Articles | Today's Clinical Lab

A clinician with gloved hands points with a pen to a model of the female reproductive system with tumors in the uterine wall.

PARP Inhibitor Delays Uterine Cancer Recurrence in Phase 2 Trial

University of Colorado Anschutz Medical Campus

There are currently no approved maintenance therapies for metastatic and recurrent uterine/endometrial cancer

A multiethnic group of five women of mixed ages stand together outdoors, each holding a breast cancer awareness ribbon near the camera.

Postsurgery Immunotherapy Doesn’t Improve Survival in Breast Cancer

European Organisation for Research and Treatment of Cancer

Adding atezolizumab immunotherapy to postsurgery chemotherapy doesn’t have the same benefits as the pre-surgery regimen

A female clinician explain a lung X-ray report to a male patient lying on the bed in a hospital room.

Arginine Starvation Abates Rare Lung Cancer

Queen Mary University of London

The treatment significantly increases the survival of people with malignant mesothelioma, according to results from Phase 3 trial

New First-Line Lymphoma Treatment Well-Tolerated in Phase 2 Trial

PrECOG Cancer Research Group

Venetoclax administered with bendamustine+rituximab as the first therapy for mantle cell lymphoma led to 85 percent complete response rate

An African-American woman holding a pink ribbon on her left breast marking breast cancer awareness.

Drug Combo Could Benefit HER2-Positive Breast Cancer Cases

American Association for Cancer Research

The HER2CLIMB-02 trial reveals significant benefits, especially for breast cancer patients with brain metastases

3D illustration of cancer cells attacking a human brain as in gliomas.

Combination Therapy Improves Rare Brain Tumors in Children

Great Ormond Street Hospital

Trials showed the effect of combination therapy on survival and quality of life in children with low- and high-grade gliomas

3D illustration of cancer cells dividing.

RNA Expression Scores Predict Response to Bladder Cancer Therapy

SWOG Cancer Research Network

Prospective trials may help assess whether molecular subtype-directed approach can improve response to neoadjuvant therapy in MIBC patients

3D illustration of a human brain with tumor.

Combo Immunotherapy Trial for Glioblastoma Commences

University of North Carolina School of Medicine

Close-up of female clinician holding a blue ribbon with both hands in front of her chest beside colon model on the table.

Treatment Combo Outperforms Standard-of-Care in Colorectal Cancer Trial

City of Hope

The novel therapeutic could provide a new option for patients with treatment-resistant KRAS gene mutation-positive colorectal cancer

Vector illustration of multiracial women standing together against breast cancer.

EPOCH Trial to Explore Ovarian, Uterine Carcinosarcoma Therapies

Walter and Eliza Hall Institute

International clinical trial exploring treatment combinations for rare and aggressive cancers in women launched in Australia

Chemotherapy